+ All Categories
Home > Documents > LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that...

LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that...

Date post: 06-Jul-2020
Category:
Upload: others
View: 6 times
Download: 0 times
Share this document with a friend
19
LUZHOU BIO-CHEM TECHNOLOGY LIMITED Corporate Presentation and 4QFY19 Results 26 February, 2020 A Mouth-Watering China Consumption Story
Transcript
Page 1: LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the

LUZHOU BIO-CHEM TECHNOLOGY LIMITED

Corporate Presentation

and 4QFY19 Results

26 February, 2020

A Mouth-Watering China Consumption Story

Page 2: LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the

2

Business Overview

Financial Highlights

Growth Strategies

Contents

Page 3: LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the

3

Business Overview

Page 4: LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the

4

Operating Climate

China’s economic growth is likely to continue to slow down due to

the on-going trade war with the United States, the weakening of the

domestic economy and the overall global slowdown.

The domestic consumption continues to be sluggish and the recent

outbreak of the COVID-19 virus, which is expected to affect the

livelihood of the Chinese people, will further dampen the market

demand.

The Group’s operations have been disrupted due to the imposition

of stop work order by the local authorities.

Due to the uncertainty of the market, the Group is concerned about

the possible prolonged duration and the extent of the disruption due

to the COVID-19.

Page 5: LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the

High price of cane sugar has resulted in food & beverage

manufacturers turning to alternative sweeteners

For comparison, the prices of sweetener products supplied by Luzhou

(as at December 2019) are as follows:

Fructose: RMB 2,524 /tonne

Dextrose: RMB 2,416/tonne

High Maltose Syrup: RMB 2,153/tonne 5

Price Comparisons to Cane Sugar

Source: Company, 中国昆商糖网

RMB/tonnes

2,000

3,500

5,000

6,500

8,000

Dec-

09

Mar-

10

Jun-1

0

Sep-1

0

Dec-

10

Mar-

11

Jun-1

1

Sep-1

1

Dec-

11

Mar-

12

Jun-1

2

Sep-1

2

Dec-

12

Mar-

13

Jun-1

3

Sep-1

3

Dec-

13

Mar-

14

Jun-1

4

Sep-1

4

Dec-

14

Mar-

15

Jun-1

5

Sep-1

5

Dec-

15

Mar-

16

Jun-1

6

Sep-1

6

Dec-

16

Mar-

17

Jun-1

7

Sep-1

7

Dec-

17

Mar-

18

Jun-1

8

Sep-1

8

Dec-

18

Mar-

19

Jun-1

9

Sep-1

9

Dec-

19

Cane sugar pricing in Nanning City, China

Page 6: LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the

1,702

2,363

1,603

1,000

1,200

1,400

1,600

1,800

2,000

2,200

2,400

2,600

2,800

3,000

Jan-18

Feb-18

Mar-18

Apr-18

May-18

Jun-18

Jul-18

Aug-18

Sep-18

Oct-18

Nov-18

Dec-18

Jan-19

Feb-19

Mar-19

Apr-19

May-19

Jun-19

Jul-19

Aug-19

Sep-19

Oct-19

Nov-19

Dec-19

Corn Sweetener Corn Starch By-Products Corn

6

RMB/tonnes (excluding taxes)

Price Trends

Source: Company

Page 7: LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the

7

Financial Highlights

Page 8: LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the

8

FY19 Financial Highlights

Group revenue decreased by 8.1% y-o-y

Gross profit margin of 8.9%, 8.2% lower y-o-y;

Net loss of RMB 88.4 million, decreased by 2.4% compared

with net loss of RMB 90.5 million in FY18

Net loss margin of 4.3%, increased by 4.9% compared with net

loss margin of 4.1% in FY18

Cash and cash equivalents of RMB 112.2 million as at

31 December, 2019 (RMB 163.7 million as at 31 December,

2018)

Page 9: LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the

9

RMB’mil 4QFY19 4QFY18y-o-y

Chg (%)FY19 FY18

y-o-yChg (%)

Revenue 558.2 560.4 (0.4) 2,042.2 2,222.8 (8.1)

Gross Profit 69.6 52.8 31.6 181.3 216.0 (16.1)

(Loss) Before Tax (14.9) (68.1) (78.2) (75.3) (85.5) 11.9

Net (Loss) (19.7) (70.4) (72.0) (88.4) (90.5) (2.4)

Gross Profit Margin 12.5% 9.4% 33.0 8.9% 9.7% (8.2)

Net (Loss) Margin (3.5%) (12.6%) (72.2) (4.3%) (4.1%) 4.9

Income Statement Highlights

4Q: Three months ended December 31

FY: Twelve months ended December 31

Page 10: LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the

10

RMB’mil

Revenue

Page 11: LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the

11

Revenue by Industry

Total Revenue: RMB 2,042.2 mil

Total Revenue: RMB 2,222.8 mil

Page 12: LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the

12

RMB’mil

Net Profit/EBITDA

FY13

Page 13: LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the

13

RMB’milAs at

end FY19As at

end FY18Chg (%)

Current Assets 531.4 626.7 (15.2)

- Cash & Cash Equivalents 112.2 163.7 (31.5)

- Inventories 196.8 235.0 (16.3)

- Trade and Other Receivables 222.5 228.0 (2.4)

Total Assets 1,056.3 1,217.5 (13.2)

Current Liabilities 706.0 602.2 17.2

- Trade and Other Payables 346.4 400.7 (13.6)

- Short Term Borrowings 342.6 192.7 77.8

Long Term Borrowings 402.0 577.4 (30.4)

Total Liabilities 1,139.8 1,212.7 (6.0)

Balance Sheet Highlights

Page 14: LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the

14

RMB’milAs at

end FY19As at

end FY18 Chg (%)

Inventory Turnover Days 42 39 7.7

Receivables Turnover Days 33 29 13.8

Payables Turnover Days 56 50 12.0

Debt to Equity Ratio# (8.9) 159.3 (105.6)

Balance Sheet Highlights

Price to Book Value* (0.4) 6.8 (105.9)

# Total interest bearing & interest-free loans / Total equity

* Based on share price of RMB 0.062 as at December 31, 2019

Page 15: LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the

15

RMB’mil FY19 FY18 Chg (%)

Net Cash Generated from Operating Activities 27.8 78.9 (64.8)

Net Cash (Used in) Investing Activities (12.5) (24.7) (49.4)

Net Cash (Used in) Financing Activities (66.8) (59.9) 11.5

Net (Decrease) in Cash & Bank Balances (51.6) (5.7) 805.3

Cash at Bank Balances at Beginning of Period 87.3 93.0 (6.1)

Cash at Bank Balances at End of Period 35.8 87.3 (59.0)

Cash Flow Statement Highlights

Page 16: LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the

16

Growth Strategies

Page 17: LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the

17

Focusing on products where the Group has pricing advantages as a

high volume producer (e.g. Sorbitol), and high margin products such

as fructose, high maltose syrup, maltitol, etc.

Continue with cost savings effort with the suspension of unprofitable

products.

Resume production when the local market condition is favorable so as

to ride on the uptrend in consumption demand and capture the market

shares to improve the Group’s revenue and profit margin.

Defer capital investment where necessary to conserve cash due to the

uncertainty of the global and domestic markets.

Growth Strategies

Page 18: LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the

Safe Harbour Statement

This presentation may contain forward looking statements that involve risks and uncertainties. Actual future performance, outcomes and results may differ materially from those expressed in forward looking statements as a result of a number of risks, uncertainties and assumptions. Representative examples of these factors include (without limitation) general industry and economic conditions, interest rate trends, cost of capital and capital availability, competition from other companies, shifts in customer demands, customers and partners, changes in operating expenses, including employee wages, benefits and training, governmental and public policy changes and the continued availability of financing in the amounts and the terms necessary to support future business. You are cautioned not to place undue reliance on this presentation and the information contain therein, which are based on current view of management on future events.

Without prejudice to or derogating from the generality of the foregoing, no representation or assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the extent permitted by applicable law, by Luzhou Bio-chem Technology Limited or its related persons (and their respective directors, associates, connected persons and/or employees) shall not be liable in any manner whatsoever for any consequences (including but not limited to any direct, indirect or consequential losses, loss of profits and damages) arising from the reliance or use of the information contain in this presentation.

Investors are advised to make their own independent evaluation from this presentation, consider their own individual investment objectives, financial situation and particular needs and consult their own professional and financial advisers as the legal, business, financial, tax and other aspects as investors may regard as relevant.

Page 19: LUZHOU BIO-CHEM TECHNOLOGY LIMITED · assurance is given by Luzhou Bio-chem Technology Limited that this presentation contains all information that an investor may require. To the

For more information, please visit

www.luzhou.sg

LUZHOU BIO-CHEM TECHNOLOGY LIMITED

THANK YOU


Recommended